110 related articles for article (PubMed ID: 2805205)
1. [Ophthalmologic complications of bone marrow transplant].
Castier P; Jouet JP; Janin-Mercier A; Bochu F; Mancel E
Bull Soc Ophtalmol Fr; 1989 Feb; 89(2):291-4. PubMed ID: 2805205
[No Abstract] [Full Text] [Related]
2. Ocular complications of bone marrow transplantation.
Livesey SJ; Holmes JA; Whittaker JA
Eye (Lond); 1989; 3 ( Pt 3)():271-6. PubMed ID: 2693135
[TBL] [Abstract][Full Text] [Related]
3. Ocular manifestations in bone marrow transplantation.
Spires R
J Ophthalmic Nurs Technol; 1993; 12(5):208-10. PubMed ID: 8301680
[TBL] [Abstract][Full Text] [Related]
4. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
[TBL] [Abstract][Full Text] [Related]
5. Depigmented macules following autologous bone-marrow transplant.
Worswick S; Pirouz A; Lee DJ
Arch Dermatol; 2011 Dec; 147(12):1460-1. PubMed ID: 22184779
[No Abstract] [Full Text] [Related]
6. Ocular manifestations of acute graft versus host disease after allogeneic bone marrow transplant.
Colón-Acevedo B; Rivera-Román L; Candelario N; Sánchez J
Bol Asoc Med P R; 2014; 106(2):30-2. PubMed ID: 25065048
[TBL] [Abstract][Full Text] [Related]
7. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous allografting and autografting of skin for ulcers in a bone marrow transplant patient.
Kamei Y; Torii S; Hasegawa M; Toriyama K; Kodera Y
Transplantation; 1993 Dec; 56(6):1530-1. PubMed ID: 8279030
[No Abstract] [Full Text] [Related]
9. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
[TBL] [Abstract][Full Text] [Related]
11. Splenectomy may reverse pancytopenia occurring after allogeneic bone marrow transplantation.
von Bueltzingsloewen A; Bordigoni P; Dorvaux Y; Witz F; Schmitt C; Chastagner P; Sommelet D
Bone Marrow Transplant; 1994 Aug; 14(2):339-40. PubMed ID: 7994254
[No Abstract] [Full Text] [Related]
12. Bone marrow transplant. Today and tomorrow.
Wikle T; Coyle K; Shapiro D
Am J Nurs; 1990 May; 90(5):48-56. PubMed ID: 2337139
[No Abstract] [Full Text] [Related]
13. Ocular manifestations of graft versus host disease following bone marrow transplantation.
Claes K; Kestelyn P
Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
[TBL] [Abstract][Full Text] [Related]
14. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease.
Pretnar J; Cernelc P; Mlakar U; Fortuna M
Bone Marrow Transplant; 1996 Oct; 18(4):826. PubMed ID: 8899209
[No Abstract] [Full Text] [Related]
15. Acquired ichthyosis in bone marrow transplant recipients.
Spelman LJ; Strutton GM; Robertson IM; Weedon D
J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous chronic graft-vs-host disease and hepatitis C virus.
Bouloc A; Pawlotsky JM; Choukroun V; Norol F; Vernant JP; Revuz J; Bagot M
Arch Dermatol; 1995 Jul; 131(7):853-5. PubMed ID: 7611812
[No Abstract] [Full Text] [Related]
17. [Venous occlusive disease of the liver and autologous bone marrow transplantation. Preventive role for heparin?].
Cahn JY; Flesch M; Plouvier E; Hervé P; Rozenbaum A
Nouv Rev Fr Hematol (1978); 1985; 27(1):27-8. PubMed ID: 3887329
[TBL] [Abstract][Full Text] [Related]
18. Is there an upper age limit for bone marrow transplantation?
Popplewell LL; Forman SJ
Bone Marrow Transplant; 2002 Feb; 29(4):277-84. PubMed ID: 11896423
[TBL] [Abstract][Full Text] [Related]
19. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
[TBL] [Abstract][Full Text] [Related]
20. Does oxypentifylline reduce the intensity of acute graft-versus-host disease following allogeneic bone marrow transplantation?
Ghosh K; Hutchinson RM
Haematologia (Budap); 1996; 28(1):45-51. PubMed ID: 9283904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]